Valeant Bends On Hospital Discounts; 'Left' Turn Ahead

Valeant Pharmaceuticals International Inc. pledged to provide hospitals up to 40% in discounts on two of the company's medicines, whose controversial high prices have gotten it into hot water. Meanwhile, short-seller Andrew Left said he was now long on Valeant, while T. Rowe Price sold 90% of its shares in the Canadian drug firm.